Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.
Gelmedix has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Gelmedix is headquartered in Newton, United States.
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.
Gelmedix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gelmedix — Funding & Investors." VCBacked, February 17, 2026, https://www.vcbacked.co/company/gelmedix. Accessed August 1, 2026.
VCBacked. (2026). Gelmedix — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/gelmedix
{{cite web |title=Gelmedix — Funding & Investors |url=https://www.vcbacked.co/company/gelmedix |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated